A
MRVI icon

AlphaQuest’s Maravai LifeSciences MRVI Stock Holding History

AlphaQuest’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,177
Closed -$13.6K – 1272
2025
Q4 		$13.6K Hold
4,177
– – ﹤0.01% 2139
2025
Q3 		$12K Hold
4,177
– – ﹤0.01% 2151
2025
Q2 		$10.1K Hold
4,177
– – ﹤0.01% 1853
2025
Q1 		$9.23K Buy
+4,177
New +$16.5K ﹤0.01% 1805
2024
Q3 		– Sell
-2,273
Closed -$16.3K – 1951
2024
Q2 		$16.3K Buy
2,273
+439
+24% +$3.79K ﹤0.01% 1300
2024
Q1 		$15.9K Buy
+1,834
New +$12.4K ﹤0.01% 1049

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaQuest's MRVI Position: Q1 2026 in Review

AlphaQuest sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 4,177 shares — an estimated $13.6K sold.

AlphaQuest first reported a position in MRVI in Q1 2024 and held it in 6 quarters. The position peaked at $16.3K in Q2 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • AlphaQuest reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 4,177 Maravai LifeSciences shares in Q1 2026, an estimated $13.6K.
  • AlphaQuest first reported a position in Maravai LifeSciences in Q1 2024 and held it in 6 quarters.
  • AlphaQuest's Maravai LifeSciences position peaked at $16.3K in Q2 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.